201 E. FIFTH STREET, CINCINNATI, OH
Amended material disclosure
David White Appointed Chief Executive Officer of Onconetix, Inc.
To Acquire LLC, USA-based, AI-Powered Humanoid Robotics Company
Onconetix, Inc. Holds Special Meeting; Reverse Stock Split Proposal Voted
Onconetix, Inc. Enters Amendment with Labcorp for Proclarix Development
News
Shareholder Director Nominations
News, Securities Holder Rights or Indentures, Material Contracts, Articles of Incorporation
FY 2025
Q3
Q2
Q1
FY 2024
Notice of Late Filing for Annual Report
Notice of Late Filing for Quarterly Report
Prospectus Filed Pursuant to Rule 425
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Amended Registration Statement for Securities
Definitive Proxy Statement
PRE 14A
PRER14A
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence